Cargando…

Molecular mechanisms of resistance to HER2-targeted therapy

Detalles Bibliográficos
Autor principal: Esteva, FJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284886/
http://dx.doi.org/10.1186/bcr2283
_version_ 1782351484983181312
author Esteva, FJ
author_facet Esteva, FJ
author_sort Esteva, FJ
collection PubMed
description
format Online
Article
Text
id pubmed-4284886
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42848862015-01-15 Molecular mechanisms of resistance to HER2-targeted therapy Esteva, FJ Breast Cancer Res Oral Presentation BioMed Central 2009 2009-06-23 /pmc/articles/PMC4284886/ http://dx.doi.org/10.1186/bcr2283 Text en Copyright © 2009 BioMed Central Ltd.
spellingShingle Oral Presentation
Esteva, FJ
Molecular mechanisms of resistance to HER2-targeted therapy
title Molecular mechanisms of resistance to HER2-targeted therapy
title_full Molecular mechanisms of resistance to HER2-targeted therapy
title_fullStr Molecular mechanisms of resistance to HER2-targeted therapy
title_full_unstemmed Molecular mechanisms of resistance to HER2-targeted therapy
title_short Molecular mechanisms of resistance to HER2-targeted therapy
title_sort molecular mechanisms of resistance to her2-targeted therapy
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284886/
http://dx.doi.org/10.1186/bcr2283
work_keys_str_mv AT estevafj molecularmechanismsofresistancetoher2targetedtherapy